Research Funding
The SMA Foundation Research Funding program supports projects that accelerate late-stage translational research or clinical trials for new SMA therapeutics.
Funder: SMA Foundation
Due Dates: Rolling (Letter of Intent required; applications by invitation only)
Funding Amounts: Typically one-year awards; multi-year projects possible but funded annually; indirect cost cap of 15%.
Summary: Supports research projects with immediate impact on late-stage translational research or clinical trials for SMA therapeutics.
Key Information: Applications accepted by invitation only; letter of intent required before full proposal.
Description
The SMA Foundation's Research Funding program is focused on accelerating the development of therapeutics for spinal muscular atrophy (SMA). Funding is strategically directed to projects with immediate relevance to late-stage translational research or clinical trials, particularly those that can have a direct and timely impact on drug discovery and clinical development for SMA. The Foundation seeks to foster significant advances in SMA treatment by supporting high-priority, goal-oriented research.
